AURELIA Trial: Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer Last updated on Aug 2, 2024 Previous Platinum Sensitive Recurrent Ovarian Cancer Next Platinum-Resistant Recurrent Ovarian Cancer
